New Alzheimer's drug's potentially fatal side effects obscured by 'soothing acronym,' doctors say
Seventy-nine-year-old Genevieve Lane volunteered to take the Alzheimer's drug Leqembi in a clinical trial because she was forgetting words and misplacing her keys.
Jun 18, 2024
0
0